Xpert MTB/RIF for diagnosis of tuberculous cervical lymphadenitis in HIV-infected patients
- PMID: 24166585
- DOI: 10.1002/lary.24478
Xpert MTB/RIF for diagnosis of tuberculous cervical lymphadenitis in HIV-infected patients
Abstract
Objectives/hypothesis: The World Health Organization endorsed the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis (TB), but there is limited information about the utility of this assay for the diagnosis of TB lymphadenitis. Therefore, the objective of this study was to assess the diagnostic accuracy of Xpert MTB/RIF assay in HIV-infected patients with palpable cervical lymph nodes.
Study design: Prospective, diagnostic test study.
Methods: Consecutive patients with cervical lymphadenopathy were prospectively enrolled between January 2011 and March 2013. Lymph node specimens were obtained through fine-needle aspiration or excisional biopsy. Mycobacterial culture was considered as the gold standard.
Results: Mycobacterium TB was cultured from 15 of 68 specimens (22.05%), and 53 specimens had negative cultures (77.94%). The sensitivity of Xpert MTB/RIF was 100% (95% CI, 74.65%-100%), and the specificity was 100% (95% CI, 91.58%-100%). Smear microscopy had a lower diagnostic performance.
Conclusion: Although based on a limited sample size, our study indicates that Xpert MTB/RIF is a useful method for the diagnosis of cervical TB lymphadenitis in HIV-infected patients, regardless of the bacillary load in smear-positive samples or the CD4 T cell count. The sensitivity, specificity, positive predictive value, and negative predictive value were similar to gold-standard culture.
Level of evidence: N/A.
Keywords: HIV; Xpert MTB/RIF; cervical lymphadenitis; extrapulmonary tuberculosis; lymph node tuberculosis.
© 2013 The American Laryngological, Rhinological and Otological Society, Inc.
Similar articles
-
Exploring the accuracy of the Xpert MTB/RIF assay in detecting lymph node tuberculosis: A systematic review and meta-analysis.PLoS One. 2025 May 7;20(5):e0321507. doi: 10.1371/journal.pone.0321507. eCollection 2025. PLoS One. 2025. PMID: 40333873 Free PMC article.
-
[Diagnosis value with Xpert Mtb/RIF assay for cervical tuberculous lymphadenitis].Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017 Sep 5;31(17):1338-1340. doi: 10.13201/j.issn.1001-1781.2017.17.010. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017. PMID: 29798226 Chinese.
-
Evaluation of Xpert® MTB/RIF and Ustar EasyNAT™ TB IAD for diagnosis of tuberculous lymphadenitis of children in Tanzania: a prospective descriptive study.BMC Infect Dis. 2016 Jun 6;16:246. doi: 10.1186/s12879-016-1578-z. BMC Infect Dis. 2016. PMID: 27268404 Free PMC article.
-
Diagnostic performance of the Xpert MTB/RIF assay for tuberculous lymphadenitis on fine needle aspirates from Ethiopia.Tuberculosis (Edinb). 2014 Sep;94(5):502-5. doi: 10.1016/j.tube.2014.05.002. Epub 2014 May 28. Tuberculosis (Edinb). 2014. PMID: 24931451
-
Xpert MTB/RIF in the Diagnosis of Mediastinal Tuberculous Lymphadenitis by Endoscopic Ultrasound-Guided Needle Aspiration Techniques: A Systematic Review and Meta-Analysis.Respiration. 2023;102(3):237-246. doi: 10.1159/000528947. Epub 2023 Jan 24. Respiration. 2023. PMID: 36693335
Cited by
-
Diagnostic Accuracy of the Xpert MTB/RIF Assay for Lymph Node Tuberculosis: A Systematic Review and Meta-Analysis.Biomed Res Int. 2019 May 19;2019:4878240. doi: 10.1155/2019/4878240. eCollection 2019. Biomed Res Int. 2019. PMID: 31236407 Free PMC article.
-
Efficacy of Xpert in tuberculosis diagnosis based on various specimens: a systematic review and meta-analysis.Front Cell Infect Microbiol. 2023 May 2;13:1149741. doi: 10.3389/fcimb.2023.1149741. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37201118 Free PMC article.
-
Exploring the accuracy of the Xpert MTB/RIF assay in detecting lymph node tuberculosis: A systematic review and meta-analysis.PLoS One. 2025 May 7;20(5):e0321507. doi: 10.1371/journal.pone.0321507. eCollection 2025. PLoS One. 2025. PMID: 40333873 Free PMC article.
-
Economic challenges associated with tuberculosis diagnostic development.Expert Rev Pharmacoecon Outcomes Res. 2014 Aug;14(4):499-510. doi: 10.1586/14737167.2014.914438. Epub 2014 Apr 28. Expert Rev Pharmacoecon Outcomes Res. 2014. PMID: 24766367 Free PMC article. Review.
-
Availability and use of molecular microbiological and immunological tests for the diagnosis of tuberculosis in europe.PLoS One. 2014 Jun 12;9(6):e99129. doi: 10.1371/journal.pone.0099129. eCollection 2014. PLoS One. 2014. PMID: 24922084 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials